Last quarter (Q3 2024), Marvel Biosciences Corp's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Marvel Biosciences Corp's net income was $-307.31K. See Marvel Biosciences Corp’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Jul 23	Jul 22	Jul 21	Jul 20
Total Revenue	$ ―	$ ―	$ ―	$ ―	$ ―
Cost of Revenue	$ 873.72K	$ 887.52K	$ ―	$ 613.10K	$ 265.20K
Gross Profit	$ -830.20K	$ -887.52K	$ ―	$ -613.10K	$ -265.20K
Operating Expense	$ 968.23K	$ 1.36M	$ 2.55M	$ 485.04K	$ 689.57K
Operating Income	$ -1.98M	$ -2.37M	$ -2.55M	$ -1.10M	$ -954.77K
Net Non Operating Interest Income Expense	$ -12.71K	$ -38.42K	$ -1.55K	$ 1.73K	$ 316.00
Other Income Expense	$ 104.90K	$ -4.78K	$ ―	$ -1.94M	$ -570.00
Pretax Income	$ -2.10M	$ -2.29M	$ -2.55M	$ -3.04M	$ -955.66K
Tax Provision	$ ―	$ ―	$ ―	$ ―	$ ―
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -2.10M	$ -2.29M	$ -2.55M	$ -3.04M	$ -955.66K
Basic EPS	$ -0.06	$ -0.06	$ -0.08	$ -0.17	$ -0.03
Diluted EPS	$ -0.06	$ -0.06	$ -0.08	$ -0.17	$ -0.03
Basic Average Shares	$ 159.14M	$ 39.66M	$ 32.76M	$ 17.70M	$ 32.59M
Diluted Average Shares	$ 159.14M	$ 39.66M	$ 32.76M	$ 17.70M	$ 32.59M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 1.84M	$ 2.25M	$ 2.55M	$ -1.10M	$ -954.77K
Net Income From Continuing And Discontinued Operation	$ -2.10M	$ -2.29M	$ -2.55M	$ -3.04M	$ -955.66K
Normalized Income	$ -1.82M	$ -1.68M	$ -1.88M	$ -322.57K	$ -955.66K
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ -2.07M	$ -2.26M	$ -2.55M	$ -3.04M	$ -955.97K
EBITDA	$ -2.07M	$ -2.26M	$ -2.55M	$ -3.04M	$ ―

Currency in USD

Marvel Biosciences Corp Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing